澳大利亚男男性行为者丙型肝炎发病率2009-2019年趋势
HIV阳性GBM的HCV发病率在2019年较2015年下降78%,使用PrEP的GBM在2019年较2016年下降80%,而HIV阴性GBM总体无显著变化。
要点
- HIV阳性GBM的HCV发病率在DAA治疗后显著下降。
- 使用PrEP的GBM在PrEP实施早期后HCV发病率下降。
- HIV阴性GBM总体HCV发病率无显著变化。
核心结论
- HIV阳性GBM的HCV发病率在DAA可获得后下降。
- HIV阴性GBM总体HCV发病率未见变化。
- 使用PrEP的GBM在澳大利亚PrEP实施早期后HCV发病率下降。
- 澳大利亚有望在2030年全球目标前消除GBM中的HCV。
研究设计与样本
- 数据来源于澳大利亚协作加强哨点监测系统。
- 纳入首次检测HCV抗体阴性且至少有一次后续检测的GBM。
- 使用泊松分布的广义线性模型分析2009-2019年HCV发病率,按HIV状态分层,并分析2016-2019年使用PrEP的HIV阴性GBM。
主要发现
- 6744例HIV阳性GBM的HCV发病率为1.03/100人年。
临床怎么用
- 应关注HIV阳性GBM和使用PrEP的GBM的HCV筛查与预防。
- HIV阴性GBM总体HCV发病率未下降,需持续监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. METHODS: Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. RESULTS: Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}: .09-.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI: .06-.64]). CONCLUSIONS: HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets.
引用
- Harney BL, Sacks-Davis R, van Santen DK, et al. The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019. Clin Infect Dis. 2022. PMID: 34698338. doi:10.1093/cid/ciab720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。